Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Oncotarget|June 18, 2020
Efficacy of osimertinib against EGFRvIII+ glioblastomaGustavo Chagoya, Shawn G Kwatra, Cory W Nanni, et al.
Molecular Cancer Therapeutics|May 6, 2024
Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time DependentStacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang, et al.
Epilepsia|September 22, 2000
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizuresC M DeGiorgio, S C Schachter, A Handforth, et al.
Neurology|July 23, 1998
Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trialA Handforth, C M DeGiorgio, S C Schachter, et al.
Journal of Translational Genetics and Genomics|March 28, 2022
Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virusM R Chambers, J B Foote, R T Bentley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2019
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with GlioblastomaPatrick Y Wen, David A Reardon, Terri S Armstrong, et al.
The New England Journal of Medicine|April 10, 2021
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade GliomasGregory K Friedman, James M Johnston, Asim K Bag, et al.
Cell Reports|February 14, 2019
Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing RadiationMutsuko Minata, Alessandra Audia, Junfeng Shi, et al.
Pageof 32